Intra-day Stock Recommendation [-]
Script Name Time Call No Buy/Sell Enter Between 1st Target 2nd Target Stop Loss High/Low Remark
Weekly Stock Recommendation [26-07-2021 to 30-07-2021] Don't Tread
Script Name Call No Buy/Sell CMP 1st Target 2nd Target Stop Loss High/Low Remark
AXISBANK W-1 Buy 755 768 785++ 748 - SL HIT
LT W-2 Buy 1611 1635 1649++ 1600 - SL HIT
TATAMOTOR W-3 Buy 295 305 310++ 290 - SL HIT
DRREDDY W-4 Buy 5422 5554 5630++ 5400 - SL HIT
INDUSINDBK W-5 Buy 989 1040 1060++ 976 - SL HIT
MGL W-6 Buy 1144 1176 1196++ 1130 - SL HIT
Mainline IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Windlas Biotech Limited IPO Details 04-08-2020 06-08-2020 ₹ 401.54 Cr ₹ 448 - ₹ 460 30 ₹ 13,800 -
Rolex Rings Limited IPO Details 28-07-2020 30-07-2020 ₹ 700 Cr ₹ 960 - 970 15 ₹ 14,550 -
Glenmark Life Sciences Limited IPO Details 27-07-2020 29-07-2020 ₹ 1513.60 Cr ₹ 695-720 20 ₹ 14,400 -
Tatva Chintan Pharma Chem Limited IPO Details 16-07-2021 20-07-2021 ₹ 500 Cr ₹ 1073-1083 13 ₹ 14,079 Available
SME IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Network People Services Technologies Limited IPO Details 28-07-2020 02-08-2020 ₹ 13.70 Cr ₹ 76 - ₹ 80 1600 ₹ 1,28,000 -
Rex Pipes and Cables IPO Details 28-07-2020 02-08-2020 ₹ 6.24 Cr ₹ 26 4000 ₹ 1,04,000 -
Gretex Corporate Services Ltd IPO Details 27-07-2020 30-07-2020 ₹ 5.13 Cr ₹ 170 800 ₹ 1,36,000 -

Sudarshan Pharma Industries Ltd IPO Details

Our Company was originally incorporated under the Companies Act, 1956 vide certificate of incorporation dated July 23, 2008 issued by the Registrar of Companies, Mumbai. Later in the year 2016, the name of the company was changed from ―Sudarshan Specialty Chemsolve Private Limited‖ to ―Sudarshan Pharma Industries Private Limited‖ under the Companies Act, 2013 pursuant to a special resolution passed by our shareholders at the EGM held on November 25, 2016 and vide certificate of incorporation dated December 17, 2016 issued by the Registrar of Companies, Mumbai. Thereafter, Our Company was converted in to a public company pursuant to a special resolution passed by our shareholders at the EGM held on December 12, 2016 and consequently name was changed to ―Sudarshan Pharma Industries Limited‖ (SPIL) vide fresh certificate of incorporation dated January 15, 2017 issued by Registrar of Companies, Mumbai. The CIN of the Company is U51496MH2008PLC184997.

Our company was promoted by Mr. Hemal V. Mehta & Mr. Sachin V. Mehta. Our promoters have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry. Driven by passion for building an integrated chemical and pharmaceutical company, backed by their more than two decades of individual experience, our Promoters have been the pillars of our Company`s growth since inception and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the chemical and pharmaceutical industry in India and abroad.
Sudarshan Pharma Industries Ltd IPO Details
Issue Open 12-06-2019
Issue Close 24-06-2019
Allotment Date 30-06-2019
Unblocked Amount 01-07-2019
Listing Date 02-07-2019
Issue Share 34,40,000 Total Equity Share
1,76,000 Reserved by Market Maker
32,64,000 Equity Share
Issue Size ₹ 25.80 Cr
IPO Price Band ₹ 75
Minimum Share Bid [Lost Size] 1600
Minimum Investment Amount [Rs]  ₹ 1,20,000
Face Value ₹ 10
Retail Allocation 50%
Listing On NSE SME
Sudarshan Pharma Industries Ltd IPO Grey Market Premium GMP]
Latest Update Premium Kostak Subject to Sauda Recommended
02-06-2019 : 08:00 PM - - - -
Sudarshan Pharma Industries Ltd IPO Financial details [in Rs, Cr]
Financial Year Total Assets Total Revenue Total Expenses Profit After Tax
FY-2014 - - - -
FY-2015 - - - -
FY-2016 8.27 37.95 37.80 0.09
FY-2017 19.93 55.72 55.26 0.15
FY-2018 30.97 89.76 88.77 0.73
30-09-2018 51.90 60.70 58.68 1.45
Sudarshan Pharma Industries Ltd IPO Valuation Details
Earnings Per Share [EPS] ₹ 1.82
Price/Earnings [P/E] Ratio 41.21
Return on Net Worth [RoNW] 14.58 %
Net Asset Value [NAV] ₹ 12.46 Per Share
Sudarshan Pharma Industries Ltd IPO Subscription Details
As on Date QIB/NII RII Total
Shared Offered 16,32,000 16,32,000 32,64,000
Day-1 [12-06-2019] 1,87,200 [0.11] 62,400 [0.04] 2,49,600 [0.08]
Day-2 [13-06-2019] 1,90,400 [0.12] 2,89,600 [0.18] 4,80,000 [0.15]
Day-3 [14-06-2019] 2,16,000 [0.13] 5,18,400 [0.32] 7,34,400 [0.23]
Day-4 [17-06-2019] 2,48,000 [0.15] 12,44,800 [0.76] 14,92,800 [0.46]
Day-5 [18-06-2019] 2,54,400 [0.16] 12,44,800 [0.76] 14,99,200 [0.46]
Day-6 [19-06-2019] 2,54,400 [0.16] 12,49,600 [0.77] 15,04,000 [0.47]
Day-7 [20-06-2019] 2,54,400 [0.16] 12,62,400 [0.77] 15,16,800 [0.47]
Day-8 [21-06-2019] 2,78,400 [0.17] 12,54,400 [0.77] 15,32,800 [0.47]
Day-9 [24-06-2019] - [-] - [-] - [-]
Day-4 [-] - [-] - [-] - [-]
Sudarshan Pharma Industries Ltd IPO Grey Market Premium
Check Grey Market Premium :- Click Here
Sudarshan Pharma Industries Ltd IPO Allotment Status
Check Allotment Status :- Click Here
Live Subscription for Sudarshan Pharma Industries Ltd IPO
Check Live Subscription :- Click Here
Download Sudarshan Pharma Industries Ltd IPO  DRHP & ASBA e-Forms
Download DRHP :- Click Here to Download
Download e-Forms NSE:- Click Here to Download
Sudarshan Pharma Industries Ltd IPO Recommendations
Live IPO Team Recommendation:- Neutral
Sudarshan Pharma Industries Ltd IPO Contact Details
Sudarshan Pharma Industries Ltd
301, 3rd Floor, Aura Biplex,
Above Kalyan Jewellers,
S V Road,
Borivali (West),
Mumbai – 400 092,
Maharashtra,
India,
Tel. No.: +91 22 242221111
Email: compliance.spil@gmail.com
Website: www.sudarshanpharma.com
Registrar of Sudarshan Pharma Industries Ltd IPO
Karvy Fintech Private Limited
Karvy Selenium Tower B, Plot 31-32, Gachibowli,
Financial District, Nanakramguda, Hyderabad 500 032 India
Tel. No.: 1-800-3454001/ +91 40 6716 2222
Fax No.: +91 40 2343 1551
E-mail: einward.ris@karvy.com
Investor Grievance Email: spil.ipo@karvy.com
Website: www.karisma.karvy.com
Contact Person: Mr. M Murali Krishna
SEBI Registration No.: INR000000221
Lead Managers of Sudarshan Pharma Industries Ltd IPO
FIRST OVERSEAS CAPITAL LIMITED
1-2 Bhupen Chambers, Ground Floor, Dalal Street,
Mumbai-400 001
Tel. No.: +91 22 40509999
Fax No.: N.A.
Email: rushabh@focl.in/ satish@focl.in/ mala@focl.in
Investor Grievance Email: investorcomplaints@focl.in
Website: www.focl.in
Contact Person: Mr. Rushabh Shroff/ Mr. Satish Sheth/ Ms. Mala Soneji
SEBI Registration No.: INM000003671
Disclaimer:-
       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.

0 Response to "Sudarshan Pharma Industries Ltd IPO Details"

Post a Comment